Suppr超能文献

美敦力公司生产的 24 毫米经导管肺动脉瓣植入后工作正常。

The Medtronic Melody® transcatheter pulmonary valve implanted at 24-mm diameter--it works.

机构信息

The Heart Center, Nationwide Children's Hospital, Columbus, Ohio.

出版信息

Catheter Cardiovasc Interv. 2013 Nov 1;82(5):816-23. doi: 10.1002/ccd.24821. Epub 2013 Aug 12.

Abstract

OBJECTIVES

We report the Melody valve implanted and/or expanded to 24-mm diameter.

BACKGROUND

The Medtronic Melody valve has been implanted up to 22 mm in the pulmonary position for over a decade.

METHODS

A retrospective chart review was performed on 82 patients who underwent Melody valve implant. Technical implant method, pre- and postimplant echocardiographic findings, and initial follow-up were reviewed.

RESULTS

Between 04/2008 and 12/2011, 13 Melody valves were successfully implanted in 11 patients, median age 35 years (range 16-61 years), in the pulmonary (bioprosthetic valve, right ventricle to pulmonary artery conduit, native valve) position (n = 9), tricuspid position (bioprosthetic valve n = 3), and aortic position (bioprosthetic valve n = 1). Ten valves were delivered on a 24-mm balloon in balloon catheter and three were implanted using a 22-mm Ensemble balloon delivery system, followed by postdilation using a 24-mm × 2-cm Atlas balloon catheter. Postimplant, the median peak systolic gradient across the pulmonary valve was 7 mm Hg and median gradient across the tricuspid valve was 3 mm Hg. There was no change in gradient across the Melody valve in the aortic position where valve prosthesis-patient mismatch was present. Postimplant intracardiac echocardiography demonstrated none or mild valve regurgitation. No more than mild regurgitation was noted at a median follow-up of 9.5 months.

CONCLUSIONS

The Melody valve can be implanted at 24 mm in the stenotic/regurgitant bioprosthetic pulmonary, tricuspid, and aortic valve, dysfunctional right ventricle to pulmonary artery conduit, and the native right ventricular outflow tract, whereas the valve remains competent with only mild regurgitation.

摘要

目的

我们报告了经扩张至 24mm 直径的 Melody 瓣膜植入和/或扩张情况。

背景

十余年来,美敦力(Medtronic)Melody 瓣膜已被植入肺动脉瓣位置,最大直径为 22mm。

方法

对 82 例行 Melody 瓣膜植入术的患者进行回顾性图表审查。回顾了技术植入方法、植入前后的超声心动图结果和初始随访情况。

结果

2008 年 4 月至 2011 年 12 月,11 名患者(中位年龄 35 岁,范围 16-61 岁)成功植入 13 枚 Melody 瓣膜,植入部位包括肺动脉瓣(生物瓣、右心室至肺动脉导管、原生瓣)(n=9)、三尖瓣(生物瓣 n=3)和主动脉瓣(生物瓣 n=1)。10 枚瓣膜采用 24mm 球囊输送,3 枚采用 22mm Ensemble 球囊输送系统植入,随后使用 24mm×2cm Atlas 球囊导管进行后扩张。植入后,肺动脉瓣的中位收缩期峰值跨瓣梯度为 7mmHg,三尖瓣的中位梯度为 3mmHg。主动脉瓣存在瓣周漏,因此瓣膜-患者不匹配,跨瓣梯度无变化。植入后,经心腔内超声心动图检查显示无或轻度瓣周漏。中位随访 9.5 个月时,瓣周漏仅为轻度。

结论

Melody 瓣膜可植入狭窄/反流性生物瓣肺动脉瓣、三尖瓣和主动脉瓣、功能不良的右心室至肺动脉导管以及原生右心室流出道,而瓣膜仍保持功能正常,仅存在轻度反流。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验